Structures by: Ramli Y.
Total: 64
4-[(<i>E</i>)-3-(4-Methylphenyl)-3-oxoprop-1-en-1-yl]benzonitrile
C17H13NO
IUCrData (2020) 5, 6 x200800
a=5.8686(2)Å b=7.4955(3)Å c=15.2792(5)Å
α=102.195(2)° β=90.649(2)° γ=90.454(2)°
1-(3-Hydroxypropyl)-3-phenylquinoxalin-2(1<i>H</i>)-one
C17H16N2O2
IUCrData (2018) 3, 11 x181633
a=8.1914(14)Å b=9.5151(16)Å c=17.781(3)Å
α=90° β=94.880(2)° γ=90°
Diethyl 4-(4-chloro-2-propyl-1<i>H</i>-imidazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate monohydrate
C19H26ClN3O4,H2O
IUCrData (2018) 3, 10 x181470
a=8.5308(11)Å b=8.5308(11)Å c=31.893(4)Å
α=90° β=90° γ=90°
5-{[(2-Hydroxyethyl)sulfanyl]methyl}quinolin-8-ol
C12H13NO2S
IUCrData (2019) 4, 5 x190625
a=11.8362(7)Å b=11.7958(7)Å c=7.8459(5)Å
α=90° β=91.6730(10)° γ=90°
2-Methyl-4-(pyridin-2-yl)-3<i>H</i>-1,5-benzodiazepine
C15H13N3
IUCrData (2018) 3, 7 x180953
a=5.9642(6)Å b=17.7004(17)Å c=11.3963(11)Å
α=90° β=100.6950(10)° γ=90°
4,4-Diphenyl-1-propyl-2-propylsulfanyl-4,5-dihydro-1<i>H</i>-imidazol-5-one
C21H24N2OS
IUCrData (2018) 3, 7 x180934
a=14.898(2)Å b=14.878(2)Å c=8.4007(13)Å
α=90° β=96.780(2)° γ=90°
1-Methyl-4-phenyl-3-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C19H13F3N4
IUCrData (2018) 3, 6 x180875
a=15.0553(10)Å b=15.7338(12)Å c=6.9701(5)Å
α=90° β=99.540(4)° γ=90°
2-(4-Hydroxyphenyl)-4,6-dimethyl-2,3-dihydropyrimidin-1-ium acetate
C12H15N2O,C2H3O2
IUCrData (2018) 3, 7 x181046
a=12.2836(4)Å b=14.5343(5)Å c=7.8596(3)Å
α=90° β=90° γ=90°
4-Phenyl-5a,6,7,8,9,9a-hexahydro-1<i>H</i>-1,5-benzodiazepin-2(5<i>H</i>)-one
C15H18N2O
IUCrData (2018) 3, 7 x181011
a=11.4283(18)Å b=9.2294(15)Å c=12.3632(19)Å
α=90° β=96.890(2)° γ=90°
1-Benzyl-3-methyl-quinoxalin-2(1<i>H</i>)-one
C16H14N2O
IUCrData (2018) 3, 3 x180390
a=7.3502(4)Å b=17.3508(10)Å c=17.9449(10)Å
α=118.2260(10)° β=100.0420(10)° γ=92.2940(10)°
Ethyl 5-(4-methylphenyl)-2,4,5,7-tetraazatricyclo[6.4.0.0^2,6^]dodeca-1(8),3,6,9,11-pentaene-3-carboxylate
C18H16N4O2
IUCrData (2018) 3, 6 x180892
a=9.2366(11)Å b=10.2045(12)Å c=16.1922(18)Å
α=90° β=92.144(2)° γ=90°
2-(3-Methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)acetic acid dihydrate
C11H10N2O3,2(H2O)
IUCrData (2018) 3, 6 x180882
a=7.7306(5)Å b=16.8048(11)Å c=9.3113(6)Å
α=90° β=102.001(2)° γ=90°
Ethyl 2-[(2<i>E</i>)-4-decyl-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-ylidene]acetate
C22H32N2O3
IUCrData (2018) 3, 5 x180680
a=28.0610(8)Å b=4.76500(10)Å c=15.3667(4)Å
α=90° β=91.5030(10)° γ=90°
1-[(Oxiran-2-yl)methyl]-3-phenylquinoxalin-2(1<i>H</i>)-one
C17H14N2O2
IUCrData (2018) 3, 4 x180610
a=12.7853(3)Å b=7.0167(2)Å c=15.4215(4)Å
α=90° β=95.7180(10)° γ=90°
Ethyl 2-(3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)acetate
C12H14N2O3
IUCrData (2018) 3, 4 x180596
a=4.8082(18)Å b=8.260(3)Å c=14.413(6)Å
α=84.072(7)° β=81.473(5)° γ=85.140(5)°
Ethyl 2-(2-oxo-3-phenyl-1,2-dihydroquinoxalin-1-yl)acetate
C18H16N2O3
IUCrData (2018) 3, 4 x180519
a=18.1710(5)Å b=4.90120(10)Å c=16.9492(5)Å
α=90° β=91.9230(10)° γ=90°
1-[(1-Butyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-3-methylquinoxalin-2(1<i>H</i>)-one
C16H19N5O
IUCrData (2018) 3, 4 x180482
a=15.8299(8)Å b=10.6270(4)Å c=9.2041(3)Å
α=90° β=98.084(4)° γ=90°
Ethyl 2-[(3-methylquinoxalin-2-yl)sulfanyl]acetate
C13H14N2O2S
IUCrData (2017) 2, 12 x171763
a=4.8078(3)Å b=7.7314(4)Å c=17.8011(10)Å
α=93.4120(10)° β=94.5640(10)° γ=103.0500(10)°
5,5-Diphenyl-3-propylimidazolidine-2,4-dione
C18H18N2O2
IUCrData (2017) 2, 12 x171808
a=9.0951(5)Å b=13.9582(7)Å c=14.1083(7)Å
α=61.6460(10)° β=80.8590(10)° γ=83.6650(10)°
4-Phenyl-2,5,5a,6,7,8,9,9a-hexahydro-1<i>H</i>-1,5-benzodiazepine-2-thione ethanol monosolvate
C15H18N2S,C2H6O
IUCrData (2018) 3, 9 x181276
a=12.0255(2)Å b=8.9303(2)Å c=15.8822(3)Å
α=90° β=95.8130(10)° γ=90°
3-Butyl-5,5-diphenylimidazolidine-2,4-dione
C19H20N2O2
IUCrData (2018) 3, 1 x180050
a=8.4920(4)Å b=8.5213(4)Å c=12.6353(6)Å
α=91.9000(10)° β=99.4100(10)° γ=115.1170(10)°
3-Benzyl-5,5-diphenylimidazolidine-2,4-dione
C22H18N2O2
IUCrData (2018) 3, 1 x171832
a=8.8897(5)Å b=13.2911(7)Å c=16.6864(9)Å
α=67.9000(10)° β=81.0270(10)° γ=74.2940(10)°
3-Hexyl-5,5-diphenylimidazolidine-2,4-dione
C21H24N2O2
IUCrData (2018) 3, 1 x180057
a=8.5395(13)Å b=8.9377(13)Å c=23.444(4)Å
α=90° β=91.066(2)° γ=90°
1-Methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one
C6H6N4O
IUCrData (2018) 3, 3 x180483
a=3.8342(2)Å b=5.5701(3)Å c=15.0346(9)Å
α=93.396(4)° β=92.812(4)° γ=92.361(4)°
Ethyl 2-[(5<i>Z</i>)-5-(4-methoxybenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]acetate
C15H15NO5S
IUCrData (2016) 1, 7 x161041
a=6.1957(2)Å b=10.6460(3)Å c=12.2909(3)Å
α=68.8450(10)° β=78.9710(10)° γ=84.9190(10)°
(7<i>R</i>)-6-Methyl-7,9-bis(prop-2-yn-1-yl)-7<i>H</i>,8<i>H</i>,9<i>H</i>-1,2,4-triazolo[4,3-<i>b</i>][1,2,4]triazepin-8-one
C12H11N5O
IUCrData (2016) 1, 8 x161245
a=7.5436(3)Å b=15.6498(6)Å c=10.9701(4)Å
α=90° β=108.3340(10)° γ=90°
2,3-Dihydrobenz[4,5]imidazo[2,1-<i>b</i>]thiazole
C9H8N2S
IUCrData (2016) 1, 12 x161948
a=12.7440(8)Å b=11.4820(7)Å c=12.8707(8)Å
α=90° β=118.2340(10)° γ=90°
(4<i>Z</i>)-4-[1-(2-Aminoanilino)ethylidene]-3-methyl-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-5-one
C18H18N4O
IUCrData (2017) 2, 2 x170256
a=8.6575(2)Å b=7.17490(10)Å c=25.3062(5)Å
α=90° β=93.7820(10)° γ=90°
5-Methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl)]sulfinyl}-1-(prop-2-yn-1-yl)-1<i>H</i>-benzimidazole
C20H21N3O3S
IUCrData (2016) 1, 10 x161695
a=4.5974(3)Å b=30.675(2)Å c=13.8090(9)Å
α=90° β=91.9610(10)° γ=90°
4-Amino-5-tetradecylamino-4<i>H</i>-1,2,4-triazol-1-ium chloride
C16H34N5,Cl
IUCrData (2016) 1, 11 x161819
a=21.5980(6)Å b=7.0666(2)Å c=13.3909(4)Å
α=90° β=105.031(2)° γ=90°
1-Benzyl-2-benzylsulfanyl-4,4-diphenyl-4,5-dihydro-1<i>H</i>-imidazol-5-one
C29H24N2OS
IUCrData (2017) 2, 1 x170033
a=8.7383(6)Å b=14.1443(9)Å c=19.2405(13)Å
α=90.7320(10)° β=92.1810(10)° γ=91.3940(10)°
5-Methyl-<i>N</i>'-[(<i>Z</i>)-4-methylbenzylidene]-1<i>H</i>-pyrazole-3-carbohydrazide
C13H14N4O
IUCrData (2016) 1, 5 x160793
a=6.32830(10)Å b=19.6204(4)Å c=10.1245(2)Å
α=90° β=105.7460(10)° γ=90°
5-Acetamido-1<i>H</i>-pyrazole-4-carboxamide monohydrate
C6H8N4O2,H2O
IUCrData (2016) 1, 6 x160947
a=9.7953(3)Å b=12.4179(3)Å c=14.4833(4)Å
α=90° β=107.4900(10)° γ=90°
Ethyl 2-[(5<i>Z</i>)-5-(4-methylbenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]acetate
C15H15NO4S
IUCrData (2016) 1, 6 x160851
a=4.73100(10)Å b=11.9082(3)Å c=13.2907(4)Å
α=87.3540(10)° β=82.3810(10)° γ=85.2830(10)°
<i>N</i>'-[(1<i>E</i>)-4-Bromobenzylidene]-5-phenyl-1<i>H</i>-pyrazole-3-carbohydrazide
C17H13BrN4O
IUCrData (2016) 1, 5 x160830
a=15.5151(3)Å b=7.17520(10)Å c=14.4593(3)Å
α=90° β=110.0720(10)° γ=90°
7,9-Didodecyl-6-methyl-3<i>H</i>,7<i>H</i>,8<i>H</i>,9<i>H</i>,9a<i>H</i>-[1,2,4]triazolo[4,3-<i>b</i>][1,2,4]triazepin-8-one
C30H55N5O
IUCrData (2016) 1, 10 x161587
a=8.8895(7)Å b=8.9652(7)Å c=19.6555(15)Å
α=95.093(3)° β=95.922(3)° γ=98.563(3)°
(4<i>Z</i>)-1-Benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C19H18N2O2
IUCrData (2016) 1, 9 x161448
a=8.2829(2)Å b=13.8636(4)Å c=15.1292(4)Å
α=72.3280(10)° β=74.9220(10)° γ=87.2520(10)°
3-[2-(5-Oxo-4,4-diphenyl-2-sulfanylideneimidazolidin-1-yl)ethyl]-1,3-oxazolidin-2-one
C20H19N3O3S
IUCrData (2017) 2, 7 x171041
a=9.1211(6)Å b=14.6521(9)Å c=14.2448(9)Å
α=90° β=104.0370(10)° γ=90°
Ethyl 2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)acetate
C19H18N2O4
IUCrData (2017) 2, 1 x170098
a=8.5041(5)Å b=8.6959(5)Å c=12.5024(8)Å
α=71.0020(10)° β=88.1650(10)° γ=72.5720(10)°
(<i>E</i>)-4-Methoxy-3,5-dimethyl-2-[(3-nitrophenyl)ethenyl]pyridine
C16H16N2O3
IUCrData (2016) 1, 12 x161966
a=23.3174(7)Å b=8.2979(2)Å c=7.2260(2)Å
α=90° β=90.8990(10)° γ=90°
1-Ethyl-3-phenyl-1,2-dihydroquinoxalin-2-one
C16H14N2O
Acta Crystallographica Section E (2021) 77, 1 18-22
a=9.2572(9)Å b=9.0531(9)Å c=15.0557(14)Å
α=90° β=99.3290(10)° γ=90°
3,4-Dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine
C20H17N3O3
Acta Crystallographica Section E (2019) 75, 1 94-98
a=10.509(9)Å b=7.435(6)Å c=21.367(16)Å
α=90° β=103.041(15)° γ=90°
1-[(1-Butyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3-methylquinoxalin-2(1<i>H</i>)-one
C16H19N5O
Acta Crystallographica Section E (2018) 74, 12 1815-1820
a=5.3265(2)Å b=9.9946(4)Å c=14.5414(5)Å
α=103.054(2)° β=100.039(2)° γ=93.108(2)°
1-Methyl-4-methylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C7H8N4S
Acta Crystallographica Section E (2014) 70, 12 o1281
a=7.9309(14)Å b=15.335(3)Å c=6.7158(12)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-{4-[(3-methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C16H17N5O3
Acta Crystallographica Section E (2018) 74, 11 1648-1652
a=7.2061(15)Å b=10.237(2)Å c=10.694(2)Å
α=95.356(3)° β=92.867(3)° γ=100.291(3)°
Ethyl 2-(4-benzyl-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl)acetate
C16H18N2O3
Acta Crystallographica Section E (2019) 75, 3 392-396
a=7.4069(9)Å b=8.1959(10)Å c=24.133(3)Å
α=90° β=90.295(2)° γ=90°
3-(4-Methoxyphenyl)-1-methyl-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C19H16N4O
Acta Crystallographica Section E (2019) 75, 5 638-641
a=6.5227(3)Å b=7.8979(4)Å c=30.7774(15)Å
α=90° β=95.389(2)° γ=90°
1,5-Diethyl-3',5'-diphenyl-1,5-dihydro-3'<i>H</i>-spiro[pyrazolo[3,4-<i>d</i>]pyrimidine-4,2'-[1,3,4]thiadiazole]
C22H22N6S
Acta Crystallographica Section E (2015) 71, 10 o769-o770
a=14.501(5)Å b=22.898(5)Å c=12.468(4)Å
α=90° β=90° γ=90°
1,5-Dibenzyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine-4(5<i>H</i>)-thione
C19H16N4S
Acta Crystallographica Section E (2015) 71, 2 o95-o96
a=4.4953(12)Å b=29.140(8)Å c=6.3889(16)Å
α=90.00° β=97.860(9)° γ=90.00°
1-Ethyl-3-methylquinoxalin-2(1<i>H</i>)-one
C11H12N2O
Acta Crystallographica Section E (2008) 64, 11 o2234
a=7.4101(6)Å b=9.1405(8)Å c=14.2960(12)Å
α=84.976(7)° β=78.717(7)° γ=88.137(7)°
3-Methyl-1-propargylquinoxalin-2(1<i>H</i>)-one
C12H10N2O
Acta Crystallographica Section E (2009) 65, 9 o2196
a=21.1240(10)Å b=4.3709(2)Å c=22.2460(10)Å
α=90.00° β=105.354(6)° γ=90.00°
3-Methyl-1-(prop-2-en-1-yl)quinoxalin-2(1<i>H</i>)-one
C12H12N2O
Acta Crystallographica Section E (2010) 66, 7 o1767
a=5.0722(5)Å b=13.4707(13)Å c=15.0507(13)Å
α=90.00° β=95.082(5)° γ=90.00°
2-Methyl-3-(<i>n</i>-octylsulfanyl)quinoxaline
C17H24N2S
Acta Crystallographica Section E (2010) 66, 4 o992
a=7.3514(3)Å b=8.2978(3)Å c=14.2168(5)Å
α=92.275(2)° β=98.706(2)° γ=103.810(2)°
1-Benzyl-3-methylquinoxalin-2(1<i>H</i>)-one
C16H14N2O
Acta Crystallographica Section E (2010) 66, 8 o1922
a=7.4433(2)Å b=17.5444(5)Å c=18.0598(7)Å
α=118.034(2)° β=100.217(2)° γ=92.7260(10)°
1,3-Bis[2-hydroxy-2-(6-methoxy-2,2-dimethyl-3a,5,6,6a-tetrahydro-2<i>H</i>- furo[2,3-<i>d</i>][1,3]dioxol-5-yl)ethyl]-2,3-dihydro-1<i>H</i>- 1,3-benzodiazol-2-one
C27H38N2O11
Acta Crystallographica Section E (2012) 68, 2 o351
a=30.5551(8)Å b=5.31320(10)Å c=17.8757(5)Å
α=90.00° β=98.267(2)° γ=90.00°
<i>N</i>'-(3-Methylquinoxalin-2-yl)-<i>N</i>'-phenylbenzohydrazide
C22H18N4O
Acta Crystallographica Section E (2011) 67, 6 o1374
a=18.6809(12)Å b=10.5840(8)Å c=9.5860(6)Å
α=90.00° β=100.108(3)° γ=90.00°
5-(Pyridin-4-ylmethyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin- 4(5<i>H</i>)-one
C11H9N5O
Acta Crystallographica Section E (2011) 67, 8 o1926
a=4.6371(3)Å b=19.2731(10)Å c=5.8593(3)Å
α=90.00° β=102.498(2)° γ=90.00°
4-Benzylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C12H10N4S
Acta Crystallographica Section E (2013) 69, 11 o1650
a=9.4737(3)Å b=5.1709(2)Å c=23.6159(8)Å
α=90.00° β=96.8230(10)° γ=90.00°
3-{2-[(3-{(<i>E</i>)-2-[4-(Dimethylamino)phenyl]ethenyl}quinoxalin-2- yl)oxy]ethyl}-1,3-oxazolidin-2-one monohydrate
C23H24N4O3,H2O
Acta Crystallographica Section E (2012) 68, 1 o241
a=7.209800(10)Å b=23.3271(4)Å c=12.3994(2)Å
α=90.00° β=98.1190(10)° γ=90.00°
2-Phenylthieno[2,3-<i>b</i>]quinoxaline
C16H10N2S
Acta Crystallographica Section E (2012) 68, 2 o396
a=6.3875(3)Å b=16.2896(8)Å c=11.6054(6)Å
α=90.00° β=96.039(3)° γ=90.00°
<i>N</i>'-Phenyl-<i>N</i>'-[3-(2,4,5-triphenyl-2,5-dihydro-1<i>H</i>-pyrazol-3-yl)quinoxalin-2-yl]benzohydrazide
C42H32N6O
Acta Crystallographica Section E (2013) 69, 8 o1320-o1321
a=12.0127(3)Å b=19.4679(5)Å c=15.2083(4)Å
α=90.00° β=106.0450(10)° γ=90.00°
1-Ethylpyrazolo[3,4-<i>d</i>]pyrimidine-4(5<i>H</i>)-thione
C7H8N4S
Acta Crystallographica Section E (2014) 70, 9 o1005-o1006
a=4.472(4)Å b=5.353(4)Å c=17.573(12)Å
α=90.00° β=93.71(4)° γ=90.00°
4-Allylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C8H8N4S
Acta Crystallographica Section E (2014) 70, 9 o1038
a=18.537(6)Å b=5.1997(17)Å c=19.059(7)Å
α=90.00° β=90.00° γ=90.00°
2-[(7-Acetyl-4-cyano-6-hydroxy-1,6-dimethyl-8-phenyl-5,6,7,8-tetrahydroisoquinolin-3-yl)sulfanyl]-<i>N</i>-phenylacetamide
C28H27N3O3S
Acta Crystallographica Section E (2021) 77, 2 121-125
a=12.0487(4)Å b=13.9821(5)Å c=15.0239(5)Å
α=90° β=106.6060(10)° γ=90°